Live feed
Filing
SC 13D/A
SC 13D/A0001437749-19-017553·GILBERTSON RYAN RANDALL
Schedule 13D ownership disclosure
Sun BioPharma, Inc.
Security class unavailable
Event date: 2019-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 212,127
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-19-017553
- Form type
- SC 13D/A
- Filer
- GILBERTSON RYAN RANDALL
- CIK
- CIK 1394821
- Filed
- Aug 28, 2019
- Reporting period
- Aug 16, 2019
- Description
- Schedule 13D beneficial ownership